By proceeding, you agree to our Terms of Use and Privacy Policy.
Returning for the 6th year, the Antifibrotic Drug Development Summit (AFDD) will host the transferrable insights you need from IPF, NASH, CKD and more in one place at one time, so you can advance the progress of your antifibrotic therapies.
Harness the knowledge for your antifibrotic research & drug development.
Gain insights from 100+ industry giants from Genentech, Gilead, Pfizer, Novartis & more to streamline your antifibrotic research & drug development.
Don't miss this unique cross-organ, cross-disease, a cross-discipline discussion forum to bridge the translational gap & transform your fibrosis research.
Discuss clinically successful therapeutics with top Translational Medicine & Biomarker experts like Adi Mor- Chemomab; Ken Dower- Pfizer & others.
At CloserStill we believe that nothing beats doing business face-to-face.
Visualizing the Future – Minimizing risk Antaros Medical is an entirely unique service provider. We are pioneering new frontiers in innovative MRI/PET imaging techniques, seamless clinical drug development and understanding of human pathophysiology.
Nordic Bioscience is the leading expert in extracellular matrix (ECM) research with 25+ years of experience in biomarker development, pre-clinical and clinical research.
Physiogenex is a leading preclinical contract research organization (CRO) specializing in metabolic disorders such as diabetes, obesity, liver diseases, dyslipidemia, atherosclerosis and cardiovascular complications.
Biomodels LLC, is an AAALAC accredited preclinical contract research organization that develops and executes predictive and highly translational efficacy studies for biotechnology and pharmaceutical companies.
Aragen is a trusted R&D and manufacturing partner to the global life sciences industry. From concept to commercial, we transform your ideas into solutions for better health.
FibroFind is a rapidly developing biomedical sciences company that has a deep understanding of fibrosis biology and has employed this knowledge to design bespoke biological assays with human tissues that can determine if a novel drug is able to preve
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.